MedPath

Cervicitis by Iontophoresis

Early Phase 1
Not yet recruiting
Conditions
CERVICITIS
Interventions
Device: IONTOPHORESIS
Drug: ORAL ANTIBIOTIC
Registration Number
NCT05675293
Lead Sponsor
October 6 University
Brief Summary

The purpose of the study is to:

Investigate effect of iontophoresis on managing uterine cervicitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
40
Inclusion Criteria
  1. All patients have vaginal discharge.
  2. All patients have irregular vaginal bleeding, especially after sexual intercourse.
  3. All patients have dyspareunia.
  4. All patients have Lower abdominal pain.
  5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
  6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.
Exclusion Criteria
  1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
  2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
  3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
  4. It either should not be used or used with extreme caution during pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EXPERIMENTAL ARMIONTOPHORESIS-
CONTROL ARMORAL ANTIBIOTIC-
Primary Outcome Measures
NameTimeMethod
Difference in change in Urine Analysis and Cervical swab results in both groups7 Days difference between pre and post tests

Presence of Pus Cells in Urine Analysis and a Positive Cervical swab results

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath